The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Oncolytic Viral Therapy Development
Choosing the right nonclinical research partner for your Oncolytic Viral Therapy development is essential to your success. This Battelle white paper will help you identify what to look for in a nonclinical research organization.
Does Your Research Partner Have the Right Expertise?
Make sure that the people who will be working on your study understand the specifics of how to design and execute toxicology and nonclinical studies for viral therapies.
Is the Staff Trained in Handling Infectious Agents?
Working with live viruses requires specialized facilities and trained staff with experience in handling procedures for biohazards and infectious agents.
Will the Bulk of The Study Be Conducted on A Single Campus?
Many CROs are specialized, performing only very specific kinds of toxicology studies or other nonclinical work. This leads to some aspects of the study needing to be outsourced.
Does Your Research Partner Have Regulatory Experience?
Regulatory considerations for oncolytic viral therapy studies are complex and require a lab with experience in navigating these regulatory pathways.
site without changing your settings, you are agreeing to accept all cookies on the site.